• Filippo Riva, MBA

    Managing Director

    Filippo Riva, MBA
    Mr. Riva brings over fifteen years of management experience in both privately held and venture-backed biotech and high-tech companies. He is member of the Board of Directors of the Swiss Biotech Association. He is also independent consultant and external advisor to the Start-up Promotion Centre of the USI (Università della Svizzera Italiana, Lugano, Switzerland). Mr. Riva holds a degree in economics from the School of Economics and Business Administration of Lugano and an MBA from the Warwick Business School, United Kingdom
  • Davide Corti, PhD

    Senior Vice President & Chief Scientific Officer

    Davide Corti, PhD
    Dr. Corti brings over ten years of experience in biotech management and at academic institutions. He is author of over 60 publications in prominent scientific journals and inventor of over fifteen patents. Dr. Corti was previously Senior Scientist and a member of the Immune Regulation Unit led by Prof. Antonio Lanzavecchia at the Institute for Research in Biomedicine (IRB) in Bellinzona. He holds a PhD in immunology from the University of Bern. He also holds a master degree in pharmaceutical biotechnology from the University of Milan, Italy, and worked in the AIDS Immunopathogenesis Unit of the San Raffaele Scientific Institute in Milan.
  • Nadia Passini, PhD

    Director R&D Operations and Translational Science

    Nadia Passini, PhD
    Dr. Passini brings more than fifteen years of experience in the pharmaceutical industry in management positions across diverse functions of the pharmaceutical value chain, including preclinical, clinical and business development. She holds a PhD in cellular and molecular biology from the Open University (United Kingdom). She previously worked at Telormedix in Lugano, Switzerland, as Director of Project Management to coordinate both preclinical and clinical projects. Earlier in her career, she held various roles and responsibilities at biotech (Bioxell) as well as biopharmaceutical (Italfarmaco and Roche) companies.